Form 4: BioAffinity Technologies CEO Maria Zannes Reports Stock Option Exercise and Share Disposals
SEC Form 4 Filing
Maria Zannes, CEO of bioAffinity Technologies, exercised stock options and disposed of shares to cover the exercise price, according to a recent SEC filing.
Summary
- On April 8, 2024, Maria Zannes, the President and CEO of bioAffinity Technologies, Inc. (BIAF), exercised stock options to acquire 64,848 shares of common stock at a price of $1.16 per share.
- Following the exercise of these options, 28,264 shares were withheld to cover the exercise price of the options, at a price of $2.65.
- After these transactions, Zannes directly owns 201,242 shares of bioAffinity Technologies common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports the execution of stock options and subsequent share disposals to cover the exercise price, which is a common practice.
Industry Context
This filing is a routine disclosure of insider transactions, which are common occurrences in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the exercise of existing stock options and a small change in the CEO's holdings.
Key Dates
| Date | Description |
|---|---|
| 04/28/2014 | Start date of the vesting period for the stock options, vesting in 7 equal monthly installments. |
| 04/08/2024 | Date of stock option exercise and share disposal. |
| 04/24/2024 | Date of signature for the SEC filing. |
Keywords
Form 4, SEC Filing, Stock Options, Maria Zannes, bioAffinity Technologies, BIAF, Insider Trading, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.